Cargando…

Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer

This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzho...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying, Zhang, Yan, Cheng, Jingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732951/
https://www.ncbi.nlm.nih.gov/pubmed/31516606
http://dx.doi.org/10.3892/ol.2019.10746
_version_ 1783449895719403520
author Hu, Ying
Zhang, Yan
Cheng, Jingliang
author_facet Hu, Ying
Zhang, Yan
Cheng, Jingliang
author_sort Hu, Ying
collection PubMed
description This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzhou University from February 2015 to October 2017. All of them underwent DCE-MRI and molybdenum target examination. Postoperatively, the pathological tissues were examined to determine their molecular typing. The sensitivity and diagnostic coincidence rates of Luminal-B breast cancer with different molecular types diagnosed by molybdenum target combined with DCE-MRI were significantly higher than those of molybdenum target or DCE-MRI alone. There were no statistical differences in sensitivity and diagnostic coincidence rates of breast cancer with different molecular types diagnosed by molybdenum target or DCE-MRI alone between the two groups (P>0.05). Molybdenum target combined with DCE-MRI in the diagnosis of different molecular types of breast cancer is better than the single imaging screening, which is of great clinical significance in the development of individualized comprehensive treatment for breast cancer patients and worthy of wide promotion in clinical practice.
format Online
Article
Text
id pubmed-6732951
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-67329512019-09-12 Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer Hu, Ying Zhang, Yan Cheng, Jingliang Oncol Lett Articles This study compared the diagnostic value of molybdenum target and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in different types of breast cancer. A retrospective analysis was performed on 120 female patients with breast cancer admitted to The First Affiliated Hospital of Zhengzhou University from February 2015 to October 2017. All of them underwent DCE-MRI and molybdenum target examination. Postoperatively, the pathological tissues were examined to determine their molecular typing. The sensitivity and diagnostic coincidence rates of Luminal-B breast cancer with different molecular types diagnosed by molybdenum target combined with DCE-MRI were significantly higher than those of molybdenum target or DCE-MRI alone. There were no statistical differences in sensitivity and diagnostic coincidence rates of breast cancer with different molecular types diagnosed by molybdenum target or DCE-MRI alone between the two groups (P>0.05). Molybdenum target combined with DCE-MRI in the diagnosis of different molecular types of breast cancer is better than the single imaging screening, which is of great clinical significance in the development of individualized comprehensive treatment for breast cancer patients and worthy of wide promotion in clinical practice. D.A. Spandidos 2019-10 2019-08-14 /pmc/articles/PMC6732951/ /pubmed/31516606 http://dx.doi.org/10.3892/ol.2019.10746 Text en Copyright: © Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Hu, Ying
Zhang, Yan
Cheng, Jingliang
Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title_full Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title_fullStr Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title_full_unstemmed Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title_short Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer
title_sort diagnostic value of molybdenum target combined with dce-mri in different types of breast cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732951/
https://www.ncbi.nlm.nih.gov/pubmed/31516606
http://dx.doi.org/10.3892/ol.2019.10746
work_keys_str_mv AT huying diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer
AT zhangyan diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer
AT chengjingliang diagnosticvalueofmolybdenumtargetcombinedwithdcemriindifferenttypesofbreastcancer